May 5, 2026- B. Braun Medical Inc. announced the launch of Rocuronium Bromide Injection, the first and only FDA-approved,* room-temperature-stable prefilled syringe—supplied as a 50 mg/5 mL (10 mg/mL) single-dose Luer lock syringe. The preservative-free formulation is provided in a sterile solution. With no refrigeration required and a 24-month shelf life, the product offers healthcare facilities greater flexibility in storage and inventory management.
B. Braun’s Rocuronium Bromide Injection is stored at room temperature, removing the need for refrigeration or temperature‑controlled transport. This simplifies pharmacy handling, supports smoother distribution and helps preserve limited refrigerated space for other medications.
With the introduction of Rocuronium Bromide Injection, B. Braun continues to strengthen its portfolio of essential injectable medications, reinforcing its role as a trusted partner in advancing healthcare safety, reliability and operational efficiency.
For additional information, please see full Prescribing Information.
Continue Reading press release.